TMC Life Sciences Bhd (0101) - Total Liabilities
Based on the latest financial reports, TMC Life Sciences Bhd (0101) has total liabilities worth RM247.47 Million MYR (≈ $62.13 Million USD) as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore TMC Life Sciences Bhd (0101) net asset momentum to track the company's year-over-year net asset growth rate.
TMC Life Sciences Bhd - Total Liabilities Trend (2006–2025)
This chart illustrates how TMC Life Sciences Bhd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does TMC Life Sciences Bhd generate to measure how efficiently the company converts operating cash flow to free cash.
TMC Life Sciences Bhd Competitors by Total Liabilities
The table below lists competitors of TMC Life Sciences Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HomeChoice Investments Ltd
JSE:HIL
|
South Africa | ZAC4.43 Billion |
|
Wuhan Golden Laser Co Ltd
SHE:300220
|
China | CN¥220.56 Million |
|
Samara Asset Group
F:SRAG
|
Germany | €36.76 Million |
|
Grupo Minsa S.A.B. de C.V
MX:MINSAB
|
Mexico | MX$2.20 Billion |
|
Vakif Gayrimenkul Yatirim Ortakligi AS
IS:VKGYO
|
Turkey | TL5.45 Billion |
|
Datawalk SA
WAR:DAT
|
Poland | zł105.76 Million |
|
Circio Holding ASA
OL:CRNA
|
Norway | Nkr23.25 Million |
|
Alpha Teknova Inc
NASDAQ:TKNO
|
USA | $33.73 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down TMC Life Sciences Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TMC Life Sciences Bhd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TMC Life Sciences Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TMC Life Sciences Bhd (2006–2025)
The table below shows the annual total liabilities of TMC Life Sciences Bhd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-08-31 | RM279.15 Million ≈ $70.08 Million |
-7.47% |
| 2024-08-31 | RM301.69 Million ≈ $75.74 Million |
-4.18% |
| 2023-08-31 | RM314.84 Million ≈ $79.04 Million |
+3.07% |
| 2022-08-31 | RM305.46 Million ≈ $76.69 Million |
+12.88% |
| 2021-08-31 | RM270.61 Million ≈ $67.94 Million |
+51.75% |
| 2020-08-31 | RM178.32 Million ≈ $44.77 Million |
+106.68% |
| 2019-08-31 | RM86.28 Million ≈ $21.66 Million |
+40.06% |
| 2018-08-31 | RM61.60 Million ≈ $15.47 Million |
+11.80% |
| 2017-08-31 | RM55.10 Million ≈ $13.83 Million |
-15.90% |
| 2016-08-31 | RM65.52 Million ≈ $16.45 Million |
+72.52% |
| 2015-08-31 | RM37.98 Million ≈ $9.53 Million |
+30.31% |
| 2014-08-31 | RM29.14 Million ≈ $7.32 Million |
+15.78% |
| 2013-08-31 | RM25.17 Million ≈ $6.32 Million |
-25.09% |
| 2012-08-31 | RM33.60 Million ≈ $8.44 Million |
-57.87% |
| 2011-08-31 | RM79.77 Million ≈ $20.03 Million |
+13.60% |
| 2009-08-31 | RM70.22 Million ≈ $17.63 Million |
+26.36% |
| 2008-08-31 | RM55.57 Million ≈ $13.95 Million |
+194.99% |
| 2007-08-31 | RM18.84 Million ≈ $4.73 Million |
+61.19% |
| 2006-08-31 | RM11.69 Million ≈ $2.93 Million |
-- |
About TMC Life Sciences Bhd
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; propert… Read more